Amarillo Biosciences (OTCMKTS:AMAR) Stock Price, News, Analysis & History

$0.21 +0.04 (+22.35 %)
(As of 03/22/2018 04:00 PM ET)
Previous Close$0.17
Today's Range$0.17 - $0.21
52-Week Range$0.15 - $0.30
Volume18,402 shs
Average Volume10,735 shs
Market Capitalization$3.94 million
P/E Ratio-6.93
Dividend YieldN/A

About Amarillo Biosciences (OTCMKTS:AMAR)

Amarillo Biosciences, Inc. is engaged in the business of biopharmaceutical research and development. The Company develops biologics for the treatment of human and animal diseases. The Company's focus is research aimed at the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia and other indications using natural human interferon alpha that is administered in a low dose oral form. The Company owns or licenses approximately two issued patents related to the low-dose oral delivery of interferon and it owns an issued patent on its dietary supplement, Maxisal. It has a pending patent, which applies low dose oral interferon to the treatment of Thrombocytopenia.

Receive AMAR News and Ratings via Email

Sign-up to receive the latest news and ratings for AMAR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry DRUGS


Debt-to-Equity RatioN/A
Current Ratio0.15%
Quick Ratio0.15%


Trailing P/E Ratio-6.93333333333333
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value($0.04) per share
Price / Book-5.20


Trailing EPS($0.03)
Net Income$-660,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-162.53%


Outstanding Shares23,160,000

Amarillo Biosciences (OTCMKTS:AMAR) Frequently Asked Questions

What is Amarillo Biosciences' stock symbol?

Amarillo Biosciences trades on the OTCMKTS under the ticker symbol "AMAR."

How were Amarillo Biosciences' earnings last quarter?

Amarillo Biosciences Inc (OTCMKTS:AMAR) issued its earnings results on Monday, November, 20th. The company reported ($0.01) earnings per share (EPS) for the quarter. View Amarillo Biosciences' Earnings History.

When will Amarillo Biosciences make its next earnings announcement?

Amarillo Biosciences is scheduled to release their next quarterly earnings announcement on Friday, April, 13th 2018. View Earnings Estimates for Amarillo Biosciences.

Who are some of Amarillo Biosciences' key competitors?

Who are Amarillo Biosciences' key executives?

Amarillo Biosciences' management team includes the folowing people:

  • Stephen T. Chen Ph.D., Chairman of the Board, Chief Executive Officer (Age 64)
  • Bernard Cohen, Chief Financial Officer, Vice President, IR Contact Officer (Age 60)
  • Yasushi Chikagami, Director (Age 75)
  • Marian Tibbits, Director (Age 57)
  • Paul Tibbits, Director (Age 74)

Has Amarillo Biosciences been receiving favorable news coverage?

Media headlines about AMAR stock have been trending somewhat positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Amarillo Biosciences earned a media sentiment score of 0.10 on Accern's scale. They also assigned press coverage about the company an impact score of 45.18 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of Amarillo Biosciences?

Shares of AMAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Amarillo Biosciences' stock price today?

One share of AMAR stock can currently be purchased for approximately $0.21.

How big of a company is Amarillo Biosciences?

Amarillo Biosciences has a market capitalization of $3.94 million. The company earns $-660,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis. Amarillo Biosciences employs 4 workers across the globe.

How can I contact Amarillo Biosciences?

Amarillo Biosciences' mailing address is 4134 BUSINESS PARK DRIVE, AMARILLO TX, 79110. The company can be reached via phone at 806-376-1741 or via email at [email protected]

MarketBeat Community Rating for Amarillo Biosciences (AMAR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  21 (Vote Outperform)
Underperform Votes:  22 (Vote Underperform)
Total Votes:  43
MarketBeat's community ratings are surveys of what our community members think about Amarillo Biosciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Amarillo Biosciences (OTCMKTS:AMAR) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Amarillo Biosciences (OTCMKTS:AMAR) Earnings History and Estimates Chart

Earnings by Quarter for Amarillo Biosciences (OTCMKTS:AMAR)

Amarillo Biosciences (OTCMKTS AMAR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/20/2017Q3 2017($0.01)ViewN/AView Earnings Details
5/12/2017Q1 2017($0.01)ViewN/AView Earnings Details
4/14/2017Q4 2016($0.01)ViewN/AView Earnings Details
11/21/2016Q3 2016($0.01)ViewN/AView Earnings Details
8/18/2016Q2 2016($0.01)ViewN/AView Earnings Details
5/16/2016Q1 2016($0.01)ViewN/AView Earnings Details
3/30/2016Q4 2015($0.01)ViewN/AView Earnings Details
11/12/2015Q3 2015($0.01)ViewN/AView Earnings Details
8/10/2015Q2 2015($0.01)ViewN/AView Earnings Details
5/15/2015Q1 2015($0.01)ViewN/AView Earnings Details
11/13/2012Q3 2012($0.04)ViewN/AView Earnings Details
8/9/2012Q2 2012($0.04)ViewN/AView Earnings Details
5/15/2012Q1 2012($0.06)ViewN/AView Earnings Details
4/19/2012Q4 2011($0.08)ViewN/AView Earnings Details
11/21/2011Q3 2011($0.15)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Amarillo Biosciences (OTCMKTS:AMAR) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Amarillo Biosciences (OTCMKTS:AMAR)

No dividend announcements for this company have been tracked by

Insider Trades

Amarillo Biosciences (OTCMKTS AMAR) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 0.01%
Insider Trades by Quarter for Amarillo Biosciences (OTCMKTS:AMAR)

Amarillo Biosciences (OTCMKTS AMAR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/22/2018Stephen T ChenCEOBuy13,500$0.18$2,430.00View SEC Filing  
3/16/2018Stephen T ChenCEOBuy3,000$0.17$510.00View SEC Filing  
3/9/2018Stephen T ChenCEOBuy20,000$0.18$3,600.00View SEC Filing  
3/7/2018Stephen T ChenCEOBuy26,000$0.24$6,240.00View SEC Filing  
2/27/2018Stephen T ChenCEOBuy10,000$0.25$2,500.00View SEC Filing  
2/22/2018Stephen T ChenCEOBuy5,000$0.28$1,400.00View SEC Filing  
1/31/2018Stephen T ChenCEOBuy10,000$0.28$2,800.00View SEC Filing  
1/18/2018Stephen T ChenCEOBuy5,000$0.25$1,250.00View SEC Filing  
1/9/2018Bernard H CohenVPBuy10,199$0.25$2,549.75View SEC Filing  
11/13/2017Stephen T ChenCEOBuy203,000$0.19$38,570.00View SEC Filing  
10/17/2017Stephen T ChenCEOBuy6,000$0.25$1,500.00View SEC Filing  
9/26/2017Stephen T ChenCEOBuy6,000$0.27$1,620.003,045,206View SEC Filing  
9/18/2017Stephen T ChenCEOBuy3,000$0.28$840.003,045,206View SEC Filing  
9/13/2017Stephen T ChenCEOBuy1,000$0.27$270.003,045,206View SEC Filing  
9/6/2017Stephen T ChenCEOBuy6,000$0.28$1,680.003,045,206View SEC Filing  
8/30/2017Stephen T ChenCEOBuy3,000$0.27$810.003,045,206View SEC Filing  
8/24/2017Stephen T ChenCEOBuy2,739$0.27$739.533,045,206View SEC Filing  
8/22/2017Stephen T ChenCEOBuy6,000$0.27$1,620.003,045,206View SEC Filing  
8/11/2017Stephen T ChenCEOBuy3,000$0.29$870.003,045,206View SEC Filing  
7/24/2017Stephen T ChenCEOBuy2,000$0.28$560.003,045,206View SEC Filing  
7/12/2017Stephen T ChenCEOBuy4,000$0.29$1,160.003,045,206View SEC Filing  
7/5/2017Stephen T ChenCEOBuy2,000$0.28$560.003,045,206View SEC Filing  
6/29/2017Stephen T ChenCEOBuy4,105$0.28$1,149.402,969,111View SEC Filing  
6/23/2017Stephen T ChenCEOBuy4,500$0.26$1,170.002,969,111View SEC Filing  
6/20/2017Stephen T ChenCEOBuy4,000$0.25$1,000.002,969,111View SEC Filing  
6/19/2017Stephen T ChenCEOBuy2,000$0.25$500.002,969,111View SEC Filing  
6/12/2017Stephen T ChenCEOBuy2,000$0.25$500.002,969,111View SEC Filing  
6/8/2017Stephen T ChenCEOBuy1,000$0.27$270.002,969,111View SEC Filing  
6/6/2017Stephen T ChenCEOBuy1,000$0.26$260.002,969,111View SEC Filing  
5/31/2017Stephen T ChenCEOBuy1,000$0.25$250.002,969,111View SEC Filing  
5/19/2017Stephen T ChenCEOBuy1,000$0.25$250.002,969,111View SEC Filing  
5/11/2017Stephen T ChenCEOBuy1,000$0.26$260.002,969,111View SEC Filing  
4/25/2017Stephen T ChenCEOBuy2,000$0.27$540.002,969,111View SEC Filing  
4/20/2017Stephen T ChenCEOBuy9,000$0.24$2,160.002,969,111View SEC Filing  
4/14/2017Stephen T ChenCEOBuy2,000$0.24$480.002,969,111View SEC Filing  
4/7/2017Stephen T ChenCEOBuy5,000$0.24$1,200.002,969,111View SEC Filing  
4/5/2017Stephen T ChenCEOBuy3,000$0.24$720.002,969,111View SEC Filing  
4/3/2017Stephen T ChenCEOBuy4,000$0.23$920.002,969,111View SEC Filing  
3/24/2017Stephen T ChenCEOBuy4,000$0.22$880.002,969,111View SEC Filing  
3/20/2017Stephen T ChenCEOBuy1,000$0.25$250.002,969,111View SEC Filing  
3/15/2017Stephen T ChenCEOBuy1,000$0.23$230.002,969,111View SEC Filing  
3/9/2017Stephen T ChenCEOBuy1,000$0.25$250.002,969,111View SEC Filing  
3/6/2017Stephen T ChenCEOBuy1,000$0.23$230.002,969,111View SEC Filing  
3/2/2017Stephen T ChenCEOBuy1,000$0.25$250.002,969,111View SEC Filing  
2/27/2017Stephen T ChenCEOBuy500$0.25$125.002,969,111View SEC Filing  
2/21/2017Stephen T ChenCEOBuy500$0.23$115.002,969,111View SEC Filing  
2/15/2017Stephen T ChenCEOBuy2,000$0.24$480.002,969,111View SEC Filing  
1/25/2017Stephen T ChenCEOBuy1,000$0.25$250.002,969,111View SEC Filing  
1/20/2017Stephen T ChenCEOBuy500$0.28$140.002,823,706View SEC Filing  
11/29/2016Stephen T ChenCEOBuy1,500$0.24$360.002,823,706View SEC Filing  
9/7/2016Stephen T ChenCEOBuy2,000$0.16$320.002,823,706View SEC Filing  
8/26/2016Stephen T ChenCEOBuy800,000$0.12$96,000.002,823,706View SEC Filing  
8/19/2016Stephen T ChenCEOBuy706$0.18$127.082,023,706View SEC Filing  
8/15/2016Stephen T ChenCEOBuy1,000$0.19$190.002,023,706View SEC Filing  
7/27/2016Stephen T ChenCEOBuy10,000$0.20$2,000.002,023,706View SEC Filing  
5/10/2016Stephen T ChenCEOBuy10,000$0.16$1,600.002,023,706View SEC Filing  
4/13/2016Stephen T ChenCEOBuy157$0.20$31.402,023,706View SEC Filing  
3/30/2016Stephen T ChenCEOBuy10,009$0.18$1,801.622,023,706View SEC Filing  
3/22/2016Stephen T ChenCEOBuy5,000$0.18$900.002,023,706View SEC Filing  
3/11/2016Stephen T ChenCEOBuy2,000$0.18$360.002,023,706View SEC Filing  
2/25/2016Stephen T ChenCEOBuy5,000$0.18$900.002,023,706View SEC Filing  
(Data available from 1/1/2013 forward)


Amarillo Biosciences (OTCMKTS AMAR) News Headlines

Amarillo Biosciences Inc. (AMAR) Releases  Earnings ResultsAmarillo Biosciences Inc. (AMAR) Releases Earnings Results - November 22 at 8:46 AM
Insider Buying: Amarillo Biosciences Inc. (AMAR) CEO Acquires 203,000 Shares of StockInsider Buying: Amarillo Biosciences Inc. (AMAR) CEO Acquires 203,000 Shares of Stock - November 14 at 1:34 PM

SEC Filings

Amarillo Biosciences (OTCMKTS:AMAR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Amarillo Biosciences (OTCMKTS:AMAR) Income Statement, Balance Sheet and Cash Flow Statement


Amarillo Biosciences (OTCMKTS AMAR) Stock Chart for Thursday, March, 22, 2018

Loading chart…

This page was last updated on 3/22/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.